What is Anti-TG (Anti-Thyroglobulin) Antibodies?

Anti-thyroglobulin antibodies (Anti-TG) are autoimmune markers that attack thyroglobulin, a protein essential for thyroid hormone production. Elevated levels indicate thyroid autoimmunity and are commonly found in Hashimoto's thyroiditis and Graves' disease.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Anti-Thyroglobulin Antibodies

Anti-thyroglobulin antibodies (Anti-TG or TgAb) are autoimmune markers that your immune system produces when it mistakenly identifies thyroglobulin as a foreign threat. Thyroglobulin is a crucial protein produced by your thyroid gland that serves as the building block for thyroid hormones T3 and T4, which regulate metabolism, energy production, and numerous bodily functions.

When your immune system creates these antibodies, they attack and damage thyroglobulin, disrupting normal thyroid hormone production. This autoimmune response can lead to inflammation of the thyroid gland and various thyroid disorders. Understanding your Anti-TG levels provides valuable insight into thyroid health and can help identify autoimmune conditions before they cause significant symptoms.

The Role of Thyroglobulin in Your Body

Thyroglobulin is a large glycoprotein exclusively produced by thyroid follicular cells. It acts as a storage reservoir for iodine and serves as the precursor for thyroid hormone synthesis. Within the thyroid gland, thyroglobulin undergoes a complex process where iodine atoms are added to create T3 (triiodothyronine) and T4 (thyroxine) hormones.

Anti-TG Antibody Reference Ranges and Clinical Significance

Anti-TG LevelCategoryClinical SignificanceRecommended Action
<4 IU/mL<4 IU/mLNormal/NegativeNo thyroid autoimmunity detectedRoutine screening only
4-9 IU/mL4-9 IU/mLBorderlinePossible early autoimmunityRetest in 6 months, check thyroid function
>9 IU/mL>9 IU/mLElevated/PositiveThyroid autoimmunity presentComplete thyroid panel, monitor every 6-12 months
>100 IU/mL>100 IU/mLSignificantly ElevatedActive autoimmune thyroid disease likelyComprehensive evaluation and treatment

Reference ranges may vary by laboratory. Results should be interpreted alongside thyroid function tests and clinical symptoms.

This protein is normally confined within the thyroid gland and shouldn't trigger an immune response. However, when thyroid tissue is damaged or inflamed, thyroglobulin can leak into the bloodstream, potentially triggering antibody production in susceptible individuals. The presence of anti-thyroglobulin antibodies indicates that your immune system has begun targeting this essential protein.

Normal Ranges and What Your Results Mean

Anti-TG antibody levels are typically measured in International Units per milliliter (IU/mL). While reference ranges can vary slightly between laboratories, understanding these general guidelines helps interpret your results.

It's important to note that having detectable Anti-TG antibodies doesn't automatically mean you have thyroid disease. Some individuals with positive antibodies maintain normal thyroid function for years. However, elevated levels do indicate an increased risk of developing thyroid disorders and warrant regular monitoring of thyroid function through comprehensive testing.

Interpreting Borderline Results

Borderline or slightly elevated Anti-TG levels (between 4-9 IU/mL) can be particularly confusing. These results might indicate early-stage autoimmune activity or could be a temporary elevation due to factors like recent illness, pregnancy, or certain medications. Your healthcare provider will likely recommend retesting in 3-6 months and may order additional thyroid function tests to get a complete picture.

Conditions Associated with Elevated Anti-TG

Several thyroid conditions are strongly associated with elevated anti-thyroglobulin antibodies. Understanding these connections helps explain why your doctor ordered this test and what elevated results might indicate for your health.

Hashimoto's Thyroiditis

Hashimoto's thyroiditis is the most common cause of elevated Anti-TG antibodies, with approximately 70-80% of Hashimoto's patients testing positive. This autoimmune condition causes chronic inflammation of the thyroid gland, gradually destroying thyroid tissue and leading to hypothyroidism. Patients with Hashimoto's often have both Anti-TG and anti-thyroid peroxidase (TPO) antibodies, with TPO antibodies typically being more specific for the condition.

Graves' Disease

While Graves' disease is primarily associated with thyroid-stimulating immunoglobulin (TSI) antibodies, about 50-60% of Graves' patients also have elevated Anti-TG levels. Unlike Hashimoto's, Graves' disease causes hyperthyroidism by stimulating excessive thyroid hormone production. The presence of Anti-TG in Graves' disease indicates broader thyroid autoimmunity.

Other Associated Conditions

Elevated Anti-TG antibodies can also occur in:

  • Postpartum thyroiditis - affecting up to 10% of new mothers
  • Subacute thyroiditis - often following viral infections
  • Thyroid cancer - particularly papillary and follicular types
  • Type 1 diabetes - due to shared autoimmune mechanisms
  • Other autoimmune conditions like rheumatoid arthritis or lupus

Symptoms That May Indicate Thyroid Antibody Issues

The presence of Anti-TG antibodies alone doesn't cause symptoms. However, when these antibodies contribute to thyroid dysfunction, you may experience various symptoms depending on whether your thyroid becomes overactive or underactive. Monitoring your symptoms alongside antibody levels helps track disease progression and treatment effectiveness.

Many people with elevated Anti-TG antibodies experience fluctuating symptoms as their thyroid function varies. This is particularly common in early Hashimoto's thyroiditis, where periods of mild hyperthyroidism (as damaged thyroid cells release stored hormones) alternate with developing hypothyroidism.

Testing Methods and What to Expect

Anti-TG antibody testing requires a simple blood draw that can be performed at a laboratory or through at-home collection services. The test is typically ordered alongside other thyroid markers for a comprehensive assessment of thyroid health. Understanding the complete thyroid panel helps provide context for your Anti-TG results.

Comprehensive Thyroid Testing

A complete thyroid evaluation typically includes:

  • TSH (Thyroid Stimulating Hormone) - the primary screening test
  • Free T4 - the main thyroid hormone in circulation
  • Free T3 - the active thyroid hormone
  • Anti-TPO antibodies - often elevated alongside Anti-TG
  • Anti-TG antibodies - to assess autoimmune activity

Testing all these markers together provides a comprehensive picture of both thyroid function and autoimmune activity, enabling more accurate diagnosis and treatment planning.

Treatment Approaches for Elevated Anti-TG

Treatment for elevated Anti-TG antibodies focuses on managing the underlying thyroid condition and reducing autoimmune activity. The approach varies depending on whether you have thyroid dysfunction and the severity of your symptoms.

Medical Management

If your thyroid function tests show hypothyroidism, your doctor will likely prescribe levothyroxine (synthetic T4) to replace missing thyroid hormones. The goal is to normalize TSH levels and alleviate symptoms. Some patients benefit from combination therapy with both T4 and T3, particularly if they continue experiencing symptoms despite normal TSH levels.

For those with normal thyroid function but elevated antibodies, treatment is more controversial. Some practitioners recommend low-dose levothyroxine to potentially slow autoimmune progression, while others prefer watchful waiting with regular monitoring every 6-12 months.

Lifestyle and Nutritional Interventions

Several lifestyle modifications may help reduce thyroid antibodies and support overall thyroid health:

  • Selenium supplementation (200 mcg daily) - shown to reduce Anti-TG levels in some studies
  • Vitamin D optimization - low levels are associated with higher antibody levels
  • Gluten-free diet - may benefit those with celiac disease or gluten sensitivity
  • Stress management through meditation, yoga, or counseling
  • Regular exercise to support immune function
  • Adequate sleep (7-9 hours nightly) for immune regulation

Monitoring and Long-term Management

Regular monitoring is crucial for individuals with elevated Anti-TG antibodies, even if thyroid function is currently normal. The frequency of testing depends on your antibody levels, symptoms, and risk factors. Most experts recommend checking thyroid function every 6-12 months for those with positive antibodies but normal thyroid function.

During pregnancy, more frequent monitoring is essential as thyroid antibodies can affect both maternal and fetal health. Women with positive thyroid antibodies have an increased risk of miscarriage and may require thyroid hormone supplementation even with normal TSH levels. Postpartum monitoring is equally important as antibody-positive women have a higher risk of developing postpartum thyroiditis.

The Connection Between Anti-TG and Other Autoimmune Conditions

Having elevated Anti-TG antibodies increases your risk of developing other autoimmune conditions. This phenomenon, called polyautoimmunity, occurs because the underlying immune dysfunction that causes thyroid antibodies can also target other organs. Common associations include Type 1 diabetes, celiac disease, rheumatoid arthritis, and pernicious anemia.

Understanding these connections emphasizes the importance of comprehensive health monitoring. If you have elevated thyroid antibodies, your healthcare provider may recommend screening for other autoimmune conditions, particularly if you develop new symptoms. Early detection and treatment of additional autoimmune conditions can significantly improve long-term health outcomes.

Taking Control of Your Thyroid Health

Discovering elevated Anti-TG antibodies can feel overwhelming, but it's important to remember that this finding gives you valuable information about your health. Many people with positive antibodies maintain normal thyroid function for years or even decades with proper monitoring and lifestyle support. The key is staying proactive about your health through regular testing, symptom awareness, and working closely with healthcare providers who understand thyroid autoimmunity.

By understanding what Anti-TG antibodies mean, recognizing associated symptoms, and implementing appropriate lifestyle modifications, you can take an active role in managing your thyroid health. Whether you're newly diagnosed or have been monitoring antibodies for years, remember that knowledge is power when it comes to preventing or managing thyroid disease.

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.[PubMed][DOI]
  2. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.[PubMed][DOI]
  3. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid. 2010;20(10):1163-1173.[PubMed][DOI]
  4. Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59(3):396-401.[PubMed][DOI]
  5. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51.[PubMed][DOI]
  6. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-2655.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Anti-TG antibodies at home?

You can test your Anti-TG antibodies at home with SiPhox Health's Core Health Program by adding the Thyroid+ expansion, which includes TPOAb, Free T4, and Free T3 testing alongside the base TSH test. This comprehensive thyroid panel provides insights into both thyroid function and autoimmune activity.

What is the normal range for Anti-TG antibodies?

Normal Anti-TG antibody levels are typically less than 4 IU/mL, though reference ranges may vary slightly between laboratories. Levels between 4-9 IU/mL are considered borderline, while levels above 9 IU/mL are clearly elevated and suggest thyroid autoimmunity.

Can Anti-TG antibodies go away on their own?

Anti-TG antibodies can fluctuate over time and may decrease with treatment or lifestyle interventions. Some people see reductions with selenium supplementation, stress management, and dietary changes. However, once present, antibodies often persist at some level, making regular monitoring important.

Should I be concerned if I have positive Anti-TG but normal thyroid function?

Having positive Anti-TG with normal thyroid function indicates an increased risk of developing thyroid problems in the future, but doesn't guarantee it. Many people maintain normal thyroid function for years. Regular monitoring every 6-12 months helps catch any changes early.

What's the difference between Anti-TG and Anti-TPO antibodies?

Both are thyroid autoantibodies, but they target different proteins. Anti-TPO antibodies attack thyroid peroxidase, an enzyme crucial for hormone production, while Anti-TG antibodies target thyroglobulin, the storage protein for thyroid hormones. Anti-TPO is more specific for Hashimoto's, but testing both provides a complete picture.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details